CureVac N.V. (CVAC)
NASDAQ: CVAC · IEX Real-Time Price · USD
3.290
+0.170 (5.45%)
At close: Jul 5, 2024, 4:00 PM
3.370
+0.080 (2.43%)
After-hours: Jul 5, 2024, 7:38 PM EDT
CureVac Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CureVac stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 18. The average target predicts an increase of 203.95% from the current stock price of 3.29.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CureVac stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 2 | 2 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +447.11% | Jul 3, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +21.58% | Apr 25, 2024 |
Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 5, 2024 |
B of A Securities | B of A Securities | Sell Maintains $10 → $8 | Sell | Maintains | $10 → $8 | +143.16% | Aug 21, 2023 |
SVB Securities | SVB Securities | Buy Initiates $13 | Buy | Initiates | $13 | +295.14% | Jun 8, 2023 |
Financial Forecast
Revenue This Year
51.33M
from 53.76M
Decreased by -4.51%
Revenue Next Year
88.14M
from 51.33M
Increased by 71.71%
EPS This Year
-0.96
from -1.18
EPS Next Year
-0.65
from -0.96
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 76.8M | 253.4M | 400.5M | 547.0M | 206.4M |
Avg | 51.3M | 88.1M | 125.2M | 243.7M | 127.0M |
Low | n/a | 13.9M | 28.8M | 51.3M | 51.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 42.8% | 393.6% | 354.4% | 336.9% | -15.3% |
Avg | -4.5% | 71.7% | 42.1% | 94.6% | -47.9% |
Low | - | -72.9% | -67.3% | -59.0% | -78.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.80 | -0.18 | 0.37 | 0.86 |
Avg | -0.96 | -0.65 | -0.34 | 0.84 |
Low | -1.52 | -0.97 | -0.60 | 0.80 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | - |
Avg | - | - | - | - |
Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.